Relationship between hyperuricemia and other cardiovascular risk factors in patients with essential, untreated arterial hypertension in the population of RISK study;Zwia̧zek hiperurykemii z innymi czynnikami ryzyka sercowo-naczyniowego u pacjentów z pierwotnym, nieleczonym nadciśnieniem tȩtniczym w populacji badania RISK

Nadcisnienie Tetnicze

Volumn 12, Issue 3, 2008, Pages 190-199

  Kostka Jeziorny, Katarzyna ^a,b   Tykarski, Andrzej ^a  

^a Uniwersytetu Medycznego Im Karola Marcinkowskiego W Poznaniu   (Poland)

^b Katedra I Klinika Hipertensjologii   (Poland)

Author keywords

Hypertension; Hyperuricemia; Metabolic syndrome

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERURICEMIA; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; OBESITY; PREVALENCE; RISK FACTOR; TARGET ORGAN; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 56649103731     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Frohlich E.D. Uric acid: a risk factor for coronary heart disease. JAMA 1993; 270: 354-359.
2. Stanton J.R., Freis ED. Serum uric acid concentration in essential hypertension. Proc. Soc. Exp. Biol. Med. 1947; 66: 193-194.
3. Freedman D.S., Williamson D.F., Gunter E.W. i wsp. Relation of serum urkacid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-Up Study. Am. J. Epidemiol. 1995; 141: 637-644.
4. Sundström J., Sullivan L., D'Agostino R.B. i wsp. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28-33.
5. Alper A.B. Jr., Chen W., Yau L. i wsp. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005; 45: 34-38.
6. Gueyffier F., Boissel J.P., Pocock S. i wsp. Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database. Circulation 1999; 100: 88-94.
7. Pearson T.A., Blair S.N., Daniels S.R. i wsp. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 update. Circulation 2002; 106: 388-391.
8. Chobanian A.V., Bakris G.L., Black H.R. i wsp. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
9. Duffy W.B., Senekjian H.O., Knight T.F. i wsp. Management of asymptomatic hyperuricemia. JAMA 1981; 246: 2215-2216.
10. Kylin E. Studien ueber das Hypertonic Hyperglykämiesyndrom. Zentrablatt fuer Innere Medizin 1923; 44: 105-127.
11. Reaven G.M. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
12. Liese A.D., Mayer-Davis E.J., Haffner S.M. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol. Rev. 1998; 20: 157-72.
13. Cannon P.J., Stason W.B., Demartini F.E. i wsp. Hyperuricemia in primary and renal hypertension. N. Engl. J. Med. 1966; 275: 457-463.
14. Matsuura F., Yamashita S., Nakamura T. i wsp. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism 1998; 47 (8): 929-933.
15. Bonora E., Targher G., Zenere M.B. i wsp. Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int. J. Obes. 1996, 20: 975-980.
16. Feig D.I., Johnson R.J. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42 (3): 247-252.
17. Bedir A., Topbas M., Tanyeri F. i wsp. Leptin might be a regulator of serum uric acid concentrations in humans. [Journal Article] Jpn. Heart J. 2003; 44 (4): 527-536.
18. Nakanishi N., Okamato M., Yoshida H. i wsp. Serum uric acid and the risk for development of hypertension and impaired fasting glucose or type II diabetesin Japanese male office workers. Eur. J. Epidemiol. 2005; 18: 523-530.
19. Tykarski A. Mechanizm hiperurykemii oraz ocena wpływu leków hipotensyjnych na transport kwasu moczowego i jego prekursorów w nefronie w nadciśnieniu tȩtniczym pierwotnym. Praca habilitacyjna. Akademia Medyczna im. Karola Marcinkowskiego w Poznaniu, Poznań 1997.
20. Zalokar J., Lellouch J., Claude J.R. i wsp. Epidemiology of serum uric acid and gout in Frenchmen. J. Chron. Dis. 1974; 27: 59-75.
21. Lee J., Sparrow D., Vokonas S. i wsp. Uric acid and Coronary Heart Disease Risk: Evidence for a Role of Uric acid in the Obesity-Insulin Resistance Syndrome. Am. J. Epidemiol. 1995; 142: 3-8.
22. Landsberg L., Troisi R., Parker D. Obesity, blood pressure and the sympathetic nervous system. Ann. Epidemiol. 1991; 1: 295-303.
23. Bedir A., Topbas M., Tanyeri F. i wsp. Leptin might be a regulator of serum uric acid concentrations in humans. [Journal Article] Jpn. Heart J. 2003; 44(4): 527-536.
24. Facchini F., Chen Y.D., Hollenbeck C.B. i wsp. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266 (21): 3008-3011.
25. Yoo T.W., Sung K.C., Shin H.S. i wsp. Relationship between serum uric acid concentration and insulin resistance and metabolic sydrome. Circ. J. 2005; 69 (8): 929-933.
26. Reed D., Labarthe D., Stallones R. Epidemiologic studies of serum uric acid levels among Micronesians. Arth. Rheum. 1972; 15: 38-43.
27. Myers A.R. Relationship of serum uric acid to risk factors in coronary heart disease. Am. J. Med. 1968; 45: 520-534.
28. Yano K., Rhoads G., Kagan A. Epidemiology of serum uric acid among 8000 Japanese-American men in Hawaii. J. Chronic Dis. 1977; 30: 171-184.
29. Klein R., Klein B., Cornoni J. i wsp. Serum uric acid: its relationship to coronary heart disease, risk factors and cardiovascular disease. Arch. Intern. Med. 1973; 132: 401-409.
30. Herman J.B., Medalie J.H., Groen J.J. Diabetes prevalence and serum uric acid. Observations among 10000 men in survey of ischemic heart disease in Israel. Diabetes 1967; 16: 858-868.
31. Herman J.B., Keyman A. Hyperglycemia and uric acid. Isr. J. Med. Sci. 1969; 5: 1048-1053.
32. Padova J., Patchefsky A., Onesti G. The effect of glucose loads on renal uric acid excretion in diabetic patients. Metabolism 1964; 13: 507-511.
33. Modan M., Halkin H., Karasik A. Elevated serum uric acid - a facet of hyperinsulinaemia. Diabetologia 1987; 30: 713-719.
34. DeFronzo R.A., Cooke C.R., Andres R. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 1975; 55: 845-854.
35. Holmes E.W., Kelley W.N., Wyngaarden J.B. The kidney and uric acid excretion in man. Kidney Int. 1972; 2: 115-123.
36. Herman J.B., Goldbourt U. Uric acid and diabetes: observations in a population study. Lancet 1982; 2: 240-249.
37. Fox H., John D., Dwosh I. i wsp. Hyperuricemia and Hypertriglyceridemia: Metabolic Basis for the Association. Metabolism 1985; 34: 8-16.
38. Gibson T., Kilbourn K., Horner I. Mechanism and treatment of hypertriglyceridemia in gout. Ann. Rheum. Dis. 1979; 38: 31-43.
39. Bluestone R., Lewis B., Mervart I. Hyperlipoproteinaemia in gout. Ann. Rheum. Dis. 1971; 30: 134-137.
40. Schonfeld G., Kudzma D.J. Type IV hyperlipoproteinemia: a critical appraisal. Arch. Intern. Med. 1973; 132: 55-60.
41. Gibson T., Graham R. Gout and hyperlipidaemia. Ann. Rheum. Dis. 1974; 33: 298-303.
42. Kelley W.N., Rosenbloom F.M., Seegmiller J.E. Excessive production of uric acid in type I glycogen storage disease. J. Pediatr. 1968; 72: 488-499.
43. Alepa F.P., Howell R.R., Klinenberg J.R. Relationships between glycogen storage disease and tophaceous gout. Am. J. Med. 1967; 42: 58-64.
44. Pagliara A.S., Karl I.E., Keating J.P. Hepatic fructose-1,6-diphosphatase deficiency: a cause for lactic acidosis and hypoglycemia in infancy. J. Clin. Invest. 1972; 51: 2115-2122.
45. Israel K.D., Michaelis O.E., Reiser S. Serum uric acid, inorganic phosphorous and glutamic-oxaloacetic transaminase and blood pressure in carbohydrate-sensitive adults consuming three different levels of sucrose. Ann. Nutr. Metab. 1983; 27: 425-434.
46. Stamler J., Berkson D., Dyer A. i wsp. Relationship of multiple variables to blood pressure - findings four Chicago Epidemiologic Studies. Epidemiology and Control of Hypertension. Ed. Oglesby Paul, Georg Thieme Publishers, Stuttgart 1975; 307-311.
47. Persky V., Dyer A., Irdissoven E. i wsp. Uric acid: a risk factor for coronary heart disease. Circ. Res. 1977; 59: 969-978.
48. Jossa F., Farinaro E., Panico S. i wsp. Serum uric acid and hypertension: The Olivetti heart study. J. Hum. Hypertens. 1994; 8: 677-687.
49. Kannel W.B., McGee D.L., Gordon T.R. A general cardiovascular risk profile: the Framingham Heart Study. Am. J. Cardiol. 1976; 38: 46-55.
50. Evans J.G., Prior I.A., Morrison R.B. The Carterton Study. 5. Serum uric acid levels of a sample of New Zealand European adults. N. Z. Med. J. 1969; 70: 306-311.
51. Myers A., Dodge H.J., Epstein F. i wsp. The relationship of serum uric acid to risk factors in coronary heart disease. Am. J. Med. 1968; 45: 520-529.
52. Fessel W.J., Siegelaub A.B., Johnson E.S. Correlates and consequences of asymptomatic hyperuricemia. Arch. Intern. Med. 1973; 132: 44-59.
53. Selby J.V., Friedman G.D., Queseberry C.P. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am. J. Epidemiol. 1990; 131: 1017-1023.
54. Zoccali C., Maio R., Mallamaci F. i wsp. Uric acid and endothelial dysfunction in essentiali hypertension. Am. Soc. Nephrol. 2006; 17: 1466-1471.
55. Perlstein T.S., Gumieniak O., Hopkins P.N. i wsp. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2005; 67: 1739-1742.
56. Viazzi F., Leoncini G., Ratto E. i wsp. Mild hyperuricemia and subclinical renal damage in untreated primary hypertension. AJH 2007; 20: 1276-1282.
57. Beck L. Requiem for gouty nephropaty. Kidney Int. 1986; 30: 280-287.
58. Ohno I., Hosoya T., Gomi H. i wsp. Serum uric acid and renal prognosis in IgA nephropathy. Nephron 2001; 87: 333-339.
59. Al-Uzri A.Y., Prather J.C., Norman D.J. i wsp. Hyperuricemia as a risk factor for renal allograft loss. American Transplant Congress 2002; streszczenie.
60. Hunsicker L.G., Adler S., Caggiula A. i wsp. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidnej Int. 1997; 51: 1908-1919.
61. Perez-Ruiz F., Calabozo M., Herrero-Beites AM. i wsp. Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts. Nephron 2000; 86: 287-291.
62. Iseki K., Oshiro S., Tozawa M. i wsp. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens. Res. 2001; 24: 691-697.
63. Shigematsu Y., Hamada M., Hiasa G. i wsp. Serum creatinine level underestimates hypertensive renal involvement in elderly patients with essential hypertension. Hypertens. Res. 1999; 22: 297-301.
64. Messerli F.H., Frohlich E.D., Dreslinski G.R. i wsp. Serum uric acid in essential hypertension: an indicator of renal vacular involvement. Ann. Intern. Med. 1980; 93: 817-821.